Home › NDC Lookup › RxCUI directory › RxCUI 198193

Ranitidine 300 MG Oral Tablet — RxCUI 198193

RxNorm drug concept · Semantic clinical drug
RxCUI 198193 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI198193
Official nameRanitidine 300 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asranitidine 300 MG (as ranitidine HCl 336 MG) Oral Tablet
FDA products mapped4
Package NDCs mapped10
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ranitidine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Ranitidine works by turning down your stomach's acid production. Less acid means conditions like ulcers, acid reflux (GERD), and an inflamed esophagus can heal — and it also helps...
  • What exactly is ranitidine supposed to do for me?
  • You can take ranitidine with or without food — eating doesn't significantly affect how well your body absorbs it. For prescription use, just follow the schedule your doctor gave yo...
  • Can I take this with food, or does it have to be on an empty stomach?
📖 Read our full Ranitidine guide →

🕸️ Concept Web — How Ranitidine 300 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ranitidine 300 MG Oral Tablet RxCUI 198193

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ranitidine 9143
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ranitidine Oral Tablet 373752
    • Ranitidine Oral Product 1164813
    • Ranitidine Pill 1164814
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Ranitidine 300 MG 328495

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ranitidine 300 MG SCDC · 328495
  • Ranitidine Oral Tablet SCDF · 373752
  • Ranitidine Oral Product SCDG · 1164813
  • Ranitidine Pill SCDG · 1164814

📦 FDA Products & Package NDCs

4 products · 10 package NDCs
10 package NDCs map to RxCUI 198193 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
53746-0253-01 100 TABLET in 1 BOTTLE (53746-253-01) Ranitidine Amneal Pharmaceuticals of New York LLC 2009-12-16
53746-0253-05 500 TABLET in 1 BOTTLE (53746-253-05) Ranitidine Amneal Pharmaceuticals of New York LLC 2009-12-16
53746-0253-10 1000 TABLET in 1 BOTTLE (53746-253-10) Ranitidine Amneal Pharmaceuticals of New York LLC 2009-12-16
53746-0253-18 180 TABLET in 1 BOTTLE (53746-253-18) Ranitidine Amneal Pharmaceuticals of New York LLC 2009-12-16
53746-0253-60 60 TABLET in 1 BOTTLE (53746-253-60) Ranitidine Amneal Pharmaceuticals of New York LLC 2009-12-16
53746-0254-01 100 TABLET in 1 BOTTLE (53746-254-01) Ranitidine Amneal Pharmaceuticals of New York LLC 2009-12-16
53746-0254-02 250 TABLET in 1 BOTTLE (53746-254-02) Ranitidine Amneal Pharmaceuticals of New York LLC 2009-12-16
53746-0254-30 30 TABLET in 1 BOTTLE (53746-254-30) Ranitidine Amneal Pharmaceuticals of New York LLC 2009-12-16
64980-0636-03 30 TABLET in 1 BOTTLE (64980-636-03) RANITIDINE Rising Pharma Holdings, Inc. 2025-12-06
64980-0637-03 30 TABLET in 1 BOTTLE (64980-637-03) RANITIDINE Rising Pharma Holdings, Inc. 2025-12-06
Observed labelers: Amneal Pharmaceuticals of New York LLC (8) · Rising Pharma Holdings, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.